287 related articles for article (PubMed ID: 10954568)
1. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.
Hermida-Matsumoto L; Resh MD
J Virol; 2000 Sep; 74(18):8670-9. PubMed ID: 10954568
[TBL] [Abstract][Full Text] [Related]
2. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
3. Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.
Bowzard JB; Visalli RJ; Wilson CB; Loomis JS; Callahan EM; Courtney RJ; Wills JW
J Virol; 2000 Sep; 74(18):8692-9. PubMed ID: 10954570
[TBL] [Abstract][Full Text] [Related]
4. Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells.
Shiraishi T; Misumi S; Takama M; Takahashi I; Shoji S
Biochem Biophys Res Commun; 2001 Apr; 282(5):1201-5. PubMed ID: 11302743
[TBL] [Abstract][Full Text] [Related]
5. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
Lee YM; Tian CJ; Yu XF
J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
[TBL] [Abstract][Full Text] [Related]
6. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
Sandefur S; Smith RM; Varthakavi V; Spearman P
J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
[TBL] [Abstract][Full Text] [Related]
7. Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication.
Koito A; Shigekane H; Matsushita S
Virology; 2003 Jan; 305(1):181-91. PubMed ID: 12504551
[TBL] [Abstract][Full Text] [Related]
8. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
Derdowski A; Ding L; Spearman P
J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
[TBL] [Abstract][Full Text] [Related]
9. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
10. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.
Dorweiler IJ; Ruone SJ; Wang H; Burry RW; Mansky LM
J Virol; 2006 Apr; 80(7):3634-43. PubMed ID: 16537631
[TBL] [Abstract][Full Text] [Related]
11. Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.
Morikawa Y; Goto T; Yasuoka D; Momose F; Matano T
J Virol; 2007 Sep; 81(18):9911-21. PubMed ID: 17609278
[TBL] [Abstract][Full Text] [Related]
12. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
13. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
14. Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.
Gomez CY; Hope TJ
J Virol; 2006 Sep; 80(17):8796-806. PubMed ID: 16912326
[TBL] [Abstract][Full Text] [Related]
15. N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles.
Liu Y; Kim YB; Löchelt M
Viruses; 2011 Nov; 3(11):2223-37. PubMed ID: 22163342
[TBL] [Abstract][Full Text] [Related]
16. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.
Simon JH; Fouchier RA; Southerling TE; Guerra CB; Grant CK; Malim MH
J Virol; 1997 Jul; 71(7):5259-67. PubMed ID: 9188594
[TBL] [Abstract][Full Text] [Related]
17. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts.
Ding L; Derdowski A; Wang JJ; Spearman P
J Virol; 2003 Feb; 77(3):1916-26. PubMed ID: 12525626
[TBL] [Abstract][Full Text] [Related]
18. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains.
Lindwasser OW; Resh MD
J Virol; 2001 Sep; 75(17):7913-24. PubMed ID: 11483736
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.
Tritel M; Resh MD
J Virol; 2000 Jul; 74(13):5845-55. PubMed ID: 10846064
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Ono A; Huang M; Freed EO
J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
